211 related articles for article (PubMed ID: 14621102)
1. Systemic inflammation in chronic obstructive pulmonary disease.
Oudijk EJ; Lammers JW; Koenderman L
Eur Respir J Suppl; 2003 Nov; 46():5s-13s. PubMed ID: 14621102
[TBL] [Abstract][Full Text] [Related]
2. [The pathobiology of COPD].
Pohl W
Wien Med Wochenschr; 2005 Mar; 155(5-6):85-9. PubMed ID: 15884487
[TBL] [Abstract][Full Text] [Related]
3. Systemic inflammation in COPD visualised by gene profiling in peripheral blood neutrophils.
Oudijk EJ; Nijhuis EH; Zwank MD; van de Graaf EA; Mager HJ; Coffer PJ; Lammers JW; Koenderman L
Thorax; 2005 Jul; 60(7):538-44. PubMed ID: 15994259
[TBL] [Abstract][Full Text] [Related]
4. Inflammation, oxidative stress and systemic effects in mild chronic obstructive pulmonary disease.
Foschino Barbaro MP; Carpagnano GE; Spanevello A; Cagnazzo MG; Barnes PJ
Int J Immunopathol Pharmacol; 2007; 20(4):753-63. PubMed ID: 18179748
[TBL] [Abstract][Full Text] [Related]
5. Local and systemic inflammation in chronic obstructive pulmonary disease.
Wouters EF
Proc Am Thorac Soc; 2005; 2(1):26-33. PubMed ID: 16113466
[TBL] [Abstract][Full Text] [Related]
6. MAP3K19 Is Overexpressed in COPD and Is a Central Mediator of Cigarette Smoke-Induced Pulmonary Inflammation and Lower Airway Destruction.
Boehme SA; Franz-Bacon K; Ludka J; DiTirro DN; Ly TW; Bacon KB
PLoS One; 2016; 11(12):e0167169. PubMed ID: 27935962
[TBL] [Abstract][Full Text] [Related]
7. 3-week inhalation exposure to cigarette smoke and/or lipopolysaccharide in AKR/J mice.
Lee KM; Renne RA; Harbo SJ; Clark ML; Johnson RE; Gideon KM
Inhal Toxicol; 2007 Jan; 19(1):23-35. PubMed ID: 17127640
[TBL] [Abstract][Full Text] [Related]
8. Systemic response to ambient particulate matter: relevance to chronic obstructive pulmonary disease.
van Eeden SF; Yeung A; Quinlam K; Hogg JC
Proc Am Thorac Soc; 2005; 2(1):61-7. PubMed ID: 16113470
[TBL] [Abstract][Full Text] [Related]
9. Chronic obstructive pulmonary disease as a systemic disease: an epidemiological perspective.
Andreassen H; Vestbo J
Eur Respir J Suppl; 2003 Nov; 46():2s-4s. PubMed ID: 14621101
[TBL] [Abstract][Full Text] [Related]
10. [Role of inflammation in the etiopathogenesis of COPD].
del Puerto-Nevado L; Pérez-Rial S; Girón-Martínez A; Peces-Barba G
Arch Bronconeumol; 2010 Dec; 46 Suppl 11():2-7. PubMed ID: 21316554
[TBL] [Abstract][Full Text] [Related]
11. Systemic manifestations in chronic obstructive pulmonary disease.
Dourado VZ; Tanni SE; Vale SA; Faganello MM; Sanchez FF; Godoy I
J Bras Pneumol; 2006; 32(2):161-71. PubMed ID: 17273586
[TBL] [Abstract][Full Text] [Related]
12. Elevated plasma levels of pigment epithelium-derived factor correlated with inflammation and lung function in COPD patients.
Li X; Wang T; Yang T; Shen Y; An J; Liu L; Dong J; Guo L; Li D; Zhang X; Chen L; Xu D; Wen F
Int J Chron Obstruct Pulmon Dis; 2015; 10():587-94. PubMed ID: 25844034
[TBL] [Abstract][Full Text] [Related]
13. Systemic effects of chronic obstructive pulmonary disease.
Agustí AG; Noguera A; Sauleda J; Sala E; Pons J; Busquets X
Eur Respir J; 2003 Feb; 21(2):347-60. PubMed ID: 12608452
[TBL] [Abstract][Full Text] [Related]
14. Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction.
Chung KF; Adcock IM
Eur Respir J; 2008 Jun; 31(6):1334-56. PubMed ID: 18515558
[TBL] [Abstract][Full Text] [Related]
15. Effects of active smoking on airway and systemic inflammation profiles in patients with chronic obstructive pulmonary disease.
Pelegrino NR; Tanni SE; Amaral RA; Angeleli AY; Correa C; Godoy I
Am J Med Sci; 2013 Jun; 345(6):440-5. PubMed ID: 22874622
[TBL] [Abstract][Full Text] [Related]
16. The non-neuronal cholinergic system in the airways: an unappreciated regulatory role in pulmonary inflammation?
Gwilt CR; Donnelly LE; Rogers DF
Pharmacol Ther; 2007 Aug; 115(2):208-22. PubMed ID: 17597218
[TBL] [Abstract][Full Text] [Related]
17. Hydrogen coadministration slows the development of COPD-like lung disease in a cigarette smoke-induced rat model.
Liu X; Ma C; Wang X; Wang W; Li Z; Wang X; Wang P; Sun W; Xue B
Int J Chron Obstruct Pulmon Dis; 2017; 12():1309-1324. PubMed ID: 28496315
[TBL] [Abstract][Full Text] [Related]
18. Integrative characterization of chronic cigarette smoke-induced cardiopulmonary comorbidities in a mouse model.
Kemény Á; Csekő K; Szitter I; Varga ZV; Bencsik P; Kiss K; Halmosi R; Deres L; Erős K; Perkecz A; Kereskai L; László T; Kiss T; Ferdinandy P; Helyes Z
Environ Pollut; 2017 Oct; 229():746-759. PubMed ID: 28648837
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of C-X-C Motif Chemokine 10 (CXCL10) Protects Mice from Cigarette Smoke-Induced Chronic Obstructive Pulmonary Disease.
Jing H; Liu L; Zhou J; Yao H
Med Sci Monit; 2018 Aug; 24():5748-5753. PubMed ID: 30118441
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting enzyme-2 overexpression attenuates inflammation in rat model of chronic obstructive pulmonary disease.
Xue T; Wei N; Xin Z; Qingyu X
Inhal Toxicol; 2014 Jan; 26(1):14-22. PubMed ID: 24417403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
